Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.056;689;292;75;
%Companies according to biotechnology used: Genetic code;36;44;18;30;
%Companies according to biotechnology used: Functional units;45;50;38;20;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;27;32;17;26;
%Companies according to biotechnology used: Bioprocesses;47;39;69;30;
%Companies according to biotechnology used: Sub-cellular organisms;8;11;4;0;
%Companies according to biotechnology used: Bio-computing;25;33;10;8;
%Companies according to biotechnology used: Nanobiotechnology;13;17;8;1;
%Companies according to biotechnology used: Other;15;15;12;32;
Companies in which biotechnology activities are: Main and/or exclusive;551;467;71;12;
Companies in which biotechnology activities are: A secondary line of business;183;108;64;11;
Companies in which biotechnology activities are: A tool necessary for production;323;114;157;53;
%Company by field(s) of ultimate application of biotechnology use: Human Health;49;63;28;1;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;20;22;13;29;
%Company by field(s) of ultimate application of biotechnology use: Food products;30;25;48;15;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;23;20;18;66;
%Company by field(s) of ultimate application of biotechnology use: Environment;13;12;17;7;
%Company by field(s) of ultimate application of biotechnology use: Industry;12;14;12;0;
Personnel in R&D in biotechnology (no. of persons);10.719;7.222;2.881;616;
Personnel in R&D in biotechnology (no. of persons): Researchers;6.131;4.585;1.339;207;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;4.588;2.637;1.542;409;
Personnel in R&D in biotechnology (no. of persons): women;6.040;4.276;1.472;292;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;3.411;2.569;737;104;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;2.629;1.706;735;188;
Personnel in R&D in biotechnology (FTE);7.750,8;5.437,6;1.946,7;366,5;
Personnel in R&D in biotechnology (FTE): Researchers;4.518,1;3.435,2;944,9;138;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;3.232,7;2.002,4;1.001,7;228,6;
Personnel in R&D in biotechnology (FTE): women;4.471,4;3.236,6;1.044,4;190,4;
Personnel in R&D in biotechnology (FTE): (women) Researchers;2.562,7;1.944;546,7;72;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;1.908,7;1.292,6;497,7;118,4;
Internal expenditure on R&D (thousands of euros);679.558;485.966;166.743;26.849;
1) By nature of the expense: Current expenses;634.631;450.150;159.316;25.166;
1.1) Remuneration to researchers;228.857;161.501;60.869;6.486;
1.2) Remuneration to technicians and assistants;104.498;57.591;40.473;6.434;
1.3) Other current expenses;301.276;231.058;57.973;12.245;
2) By nature of the expense: Capital expenses;44.927;35.816;7.427;1.683;
2.1) Land and buildings;2.585;1.409;1.078;98;
2.2) Equipment and instruments;23.569;17.290;4.766;1.513;
2.3) Acquisition of specific R&D software;1.392;1.193;196;3;
2.4) Otros productos de propiedad intelectual específicos para I+D;17.381;15.923;1.388;70;
1) By origin of the funds: National funds;556.297;390.804;140.672;24.820;
1.1) Own funds;387.010;235.228;128.729;23.053;
1.2) From companies;86.025;81.958;4.067;0;
1.3) Public Administration funds;74.764;65.121;7.876;1.767;
1.4) From Universities;408;408;0;0;
1.5) From non profit private institutions;8.090;8.090;0;0;
1) By origin of the funds: Foreign funds;123.262;95.161;26.071;2.029;
2.1) From EU programmes;25.125;22.065;2.915;145;
2.2) Other foreign funds;98.137;73.097;23.156;1.884;
Purchase of R&D services in biotechnology (thousands of euros);147.558;85.114;61.830;614;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;76.875;25.665;50.761;450;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;70.683;59.449;11.070;165;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;49;58;30;33;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;14;13;13;23;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;16;16;14;30;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;13;16;9;7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;18;21;11;14;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;18;21;10;14;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;17;18;16;16;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;40;34;28;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;51;54;44;50;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;18;19;13;22;
% Companies that have requested biotechnology patents in Biotechnology;16;19;9;4;
Number of patents requested;746;591;120;34;
% Companies with income of an international origin related to biotechnological activities;23,3;27,7;17,3;5,7;
% Turnover representing income of an international origin related to biotechnological activities;1,2;3;1,1;0,6;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;60,4;54,5;61,2;100;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;39,6;45,5;38,8;.;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;80,9;77,9;81,3;100;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;17,8;15,5;18,4;.;
% Income of an international origin related with activities according to the classification: Operating source abroad;1,3;6,4;0,4;.;
% Income of an international origin related with activities according to the classification: Other;0,1;0,2;0;.;
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute